Literature DB >> 35359243

Neural Differentiation of Human-Induced Pluripotent Stem Cells (hiPSc) on Surface-Modified Nanofibrous Scaffolds Coated with Platelet-Rich Plasma.

Reza Moazamiyanfar1, Raheleh Halabian2, Marzieh Ghollasi3, Delaram Poormoghadam4, Maliheh Entezari5, Seyed Ehsan Endorami6.   

Abstract

The field of tissue engineering exploits living cells in a variety of ways to restore, maintain, or enhance tissues and organs. Between stem cells, human induced pluripotent stem cells (hiPSCs), are very important due to their wide abilities. Growth factors can support proliferation, differentiation, and migration of hiPSCs. Platelet-rich plasma (PRP) could be used as the source of growth factors for hiPSCs. In the present study, proliferation and neural differentiation of hiPSCs on surface-modified nanofibrous Poly-L-lactic acid (PLLA) coated with platelet-rich plasma was investigated. The results of in vitro analysis showed that on the surface, which was modified nanofibrous scaffolds coated with platelet-rich plasma, significantly enhanced hiPSCs proliferation and neural differentiation were observed. Whereas the MTT ([3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide]) results showed biocompatibility of surface-modified nanofibrous scaffolds coated with platelet-rich plasma and the usage of these modified nanoscaffolds in neural tissue engineering in vivo is promising for the future.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Human induced pluripotent stem cells; Nanofibrous scaffolds; Neural differentiation; PLLA; Platelet-rich plasma

Mesh:

Year:  2022        PMID: 35359243     DOI: 10.1007/s11064-022-03584-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  50 in total

Review 1.  Tissue engineering strategies for nervous system repair.

Authors:  P A Tresco
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

Review 2.  Induced pluripotency: history, mechanisms, and applications.

Authors:  Matthias Stadtfeld; Konrad Hochedlinger
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

3.  Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

Authors:  Frank Soldner; Dirk Hockemeyer; Caroline Beard; Qing Gao; George W Bell; Elizabeth G Cook; Gunnar Hargus; Alexandra Blak; Oliver Cooper; Maisam Mitalipova; Ole Isacson; Rudolf Jaenisch
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

4.  Cell cycle activation and CNS injury.

Authors:  Bogdan A Stoica; Kimberly R Byrnes; Alan I Faden
Journal:  Neurotox Res       Date:  2009-04-21       Impact factor: 3.911

5.  Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome.

Authors:  Jiayin Yang; Jie Cai; Ya Zhang; Xianming Wang; Wen Li; Jianyong Xu; Feng Li; Xiangpeng Guo; Kang Deng; Mei Zhong; Yonglong Chen; Liangxue Lai; Duanqing Pei; Miguel A Esteban
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

Review 6.  Induced pluripotent stem cells: a new approach for physiological research.

Authors:  Kurt Pfannkuche; Tobias Hannes; Markus Khalil; Monireh Soroush Noghabi; Amir Morshedi; Jürgen Hescheler; Peter Dröge
Journal:  Cell Physiol Biochem       Date:  2010-08-24

Review 7.  Techniques of peripheral nerve repair.

Authors:  L B Dahlin
Journal:  Scand J Surg       Date:  2008       Impact factor: 2.360

Review 8.  Stem cell repair of central nervous system injury.

Authors:  Qilin Cao; Richard L Benton; Scott R Whittemore
Journal:  J Neurosci Res       Date:  2002-06-01       Impact factor: 4.164

9.  Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.

Authors:  Mason A Israel; Shauna H Yuan; Cedric Bardy; Sol M Reyna; Yangling Mu; Cheryl Herrera; Michael P Hefferan; Sebastiaan Van Gorp; Kristopher L Nazor; Francesca S Boscolo; Christian T Carson; Louise C Laurent; Martin Marsala; Fred H Gage; Anne M Remes; Edward H Koo; Lawrence S B Goldstein
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

Review 10.  Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application.

Authors:  Changsung Kim
Journal:  Blood Res       Date:  2014-03-24
View more
  1 in total

1.  Osteogenic differentiation of pre-conditioned bone marrow mesenchymal stem cells with Nisin on modified poly-L-lactic-acid nanofibers.

Authors:  Fariba Sadraei; Marzieh Ghollasi; Fatemeh Khakpai; Raheleh Halabian; Hora Jalali Tehrani
Journal:  Regen Ther       Date:  2022-08-27       Impact factor: 3.651

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.